SeaStar Medical Holding Corporation(ICU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICU SeaStar Medical Holding Corporation

Post-Market Trading 11-15 19:45:01 EST

2.19

+0.23

+11.73%

盘后2.21

+0.02+0.91%

19:35 EST

High2.26	Low1.99	Vol456.28K
Open1.99	D1 Closing1.96	Amplitude13.78%
Mkt Cap9.56M	Tradable Cap9.39M	Total Shares4.36M
T/O989.63K	T/O Rate10.64%	Tradable Shares4.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ICU","market":"US","secType":"STK","nameCN":"SeaStar Medical Holding Corporation","latestPrice":2.19,"timestamp":1731704400000,"preClose":1.96,"halted":0,"volume":456279,"hourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.19,"latestTime":"19:35 EST","volume":2660,"amount":5803.283962,"timestamp":1731717350289},"delay":0,"floatShares":4288297,"shares":4363031,"eps":-15.723378,"marketStatus":"Post-Market Trading","change":0.23,"latestTime":"11-15 19:45:01 EST","open":1.99,"high":2.26,"low":1.99,"amount":989634.4281681,"amplitude":0.137755,"askPrice":2.22,"askSize":560,"bidPrice":2.14,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-15.723378,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1731718800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.96,"preHourTrading":{"tag":"盘前","latestPrice":2.01,"preClose":1.96,"latestTime":"09:29 EST","volume":3107,"amount":6453.400253299999,"timestamp":1731680945053},"postHourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.19,"latestTime":"19:35 EST","volume":2660,"amount":5803.283962,"timestamp":1731717350289},"volumeRatio":1.555265},"requestUrl":"/m/hq/s/ICU/wiki","defaultTab":"wiki","newsList":[{"id":"2483376992","title":"SeaStar Medical reaches milestone of 100th QUELIMMUNE commercial device","url":"https://stock-news.laohu8.com/highlight/detail?id=2483376992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483376992?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:35","pubTimestamp":1731677717,"startTime":"0","endTime":"0","summary":"SeaStar Medical (ICU) has begun shipping QUELIMMUNE to a third hospital customer. QUELIMMUNE is the Company’s Selective Cytopheretic Device, SCD, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seastar-medical-reaches-milestone-of-100th-quelimmune-commercial-device?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seastar-medical-reaches-milestone-of-100th-quelimmune-commercial-device?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICU"],"gpt_icon":0},{"id":"2483712375","title":"SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer","url":"https://stock-news.laohu8.com/highlight/detail?id=2483712375","media":"GlobeNewswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483712375?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:30","pubTimestamp":1731677400,"startTime":"0","endTime":"0","summary":"DENVER, Nov.  15, 2024  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/15/2982001/0/en/SeaStar-Medical-Reaches-Milestone-of-100th-QUELIMMUNE-Commercial-Device-as-Shipments-Begin-to-its-Third-Hospital-Customer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU","BK4082","HUD","SCD"],"gpt_icon":0},{"id":"2483878326","title":"ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2483878326","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483878326?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:44","pubTimestamp":1731667442,"startTime":"0","endTime":"0","summary":"Shareholders might have noticed that ICU Medical, Inc.  filed its third-quarter result this time last week. The early response was not positive, with shares down 3.7% to US$172 in the past week. Revenues of US$589m beat expectations by a respectable 2.2%, although statutory losses per share increased. ICU Medical lost US$1.35, which was 87% more than what the analysts had included in their models. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on ICU Medical after the latest results.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-inc-nasdaq-icui-104402651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICUI","ICU",".IXIC","NDAQ"],"gpt_icon":0},{"id":"2483331388","title":"Seastar Medical Faces Distribution Challenges with Self-Marketing of QUELIMMUNE","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483331388?lang=en_us&edition=fundamental","pubTime":"2024-11-15 14:01","pubTimestamp":1731650510,"startTime":"0","endTime":"0","summary":"Seastar Medical Holding Corporation (ICU) has disclosed a new risk, in the Supply Chain category. Seastar Medical Holding Corporation recently ende...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/seastar-medical-faces-distribution-challenges-with-self-marketing-of-quelimmune?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/seastar-medical-faces-distribution-challenges-with-self-marketing-of-quelimmune?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICU"],"gpt_icon":0},{"id":"2483730078","title":"ICU Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2483730078","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483730078?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:43","pubTimestamp":1731581021,"startTime":"0","endTime":"0","summary":"NasdaqGS:ICUI Earnings and Revenue Growth November 14th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 2.2%. Earnings per share  missed analyst estimates by 87%.Looking ahead, revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US.The company's shares are down 2.3% from a week ago.Don't forget that there may still be risks. For instance, we've identified   2 warning signs for ICU Medical   you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-third-quarter-2024-104341523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICU","ICUI"],"gpt_icon":0},{"id":"2483894622","title":"SeaStar Medical Holding Corp reports results for the quarter  - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483894622","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483894622?lang=en_us&edition=fundamental","pubTime":"2024-11-14 11:53","pubTimestamp":1731556437,"startTime":"0","endTime":"0","summary":"SeaStar Medical Holding Corp reports results for the quarter  - Earnings SummarySeaStar Medical Holding Corp ICU.OQ reported a quarterly adjusted loss of $1.10 per share for the quarter , higher than ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL8N3ML03L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU"],"gpt_icon":0},{"id":"2483211861","title":"Otsuka, ICU Medical Launch Joint Venture in North America","url":"https://stock-news.laohu8.com/highlight/detail?id=2483211861","media":"MT Newswires Live","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483211861?lang=en_us&edition=fundamental","pubTime":"2024-11-14 07:28","pubTimestamp":1731540530,"startTime":"0","endTime":"0","summary":"Otsuka  unit Otsuka Pharmaceutical Factory and ICU Medical have formed a joint venture with Otsuka Pharmaceutical Factory's US subsidiary, according to a Wednesday filing on the Tokyo Stock Exchange.Under the JV,  Otsuka Pharmaceutical Factory America will own a 60% stake in the newly established company.The venture, set to begin operations in Q2 2025, will focus on IV solutions and clinical nutrition products in North America, amid ongoing shortages.ICU Medical will transfer its IV business to the new company.Price : $9110.00, Change: $-230, Percent Change: -2.47%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0240877869.USD","SG9999015978.USD","ICUI","SG9999015986.USD","BK4082","SG9999015952.SGD","JYNT","SG9999015945.SGD","LU0106261612.USD","LU0240878834.USD","LU0205194284.USD","BK4198","BK4185","LU0205193047.USD","LU0012050646.USD","ICU"],"gpt_icon":0},{"id":"2483397866","title":"SeaStar Medical Holding Q3 2024 GAAP EPS $(1.10) Beats $(1.13) Estimate, Sales $68.00K Miss $75.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483397866","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483397866?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:08","pubTimestamp":1731535734,"startTime":"0","endTime":"0","summary":"SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(1.10) per share which beat the analyst consensus estimate of $(1.13) by 2.65 percent.  The company reported quarterly sales of $68.00 thousand which","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41957295/seastar-medical-holding-q3-2024-gaap-eps-1-10-beats-1-13-estimate-sales-68-00k-miss-75-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SeaStar Medical Holding Q3 2024 GAAP EPS $(1.10) Beats $(1.13) Estimate, Sales $68.00K Miss $75.00K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU"],"gpt_icon":0},{"id":"2483668148","title":"SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483668148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483668148?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:05","pubTimestamp":1731535522,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA7TY8FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICU"],"gpt_icon":0},{"id":"2483866207","title":"SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483866207","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483866207?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:05","pubTimestamp":1731535500,"startTime":"0","endTime":"0","summary":"DENVER, Nov. 13, 2024  -- SeaStar Medical Holding Corporation  , a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports financial results for the three and nine months ended September 30, 2024, and provides a business update.“Beginning in the fourth quarter, we are able to recognize 100% of the sales value to direct end-user customers as revenue, and we expect to continue to add direct end-user customers going forward,” continued Mr. Schlorff. “Last month we presented economic data supporting the significant potential cost-saving benefits of QUELIMMUNE to the healthcare system in treating critically ill children with acute kidney injury , which we believe will further aid in achieving our goal of adding two to three or more hospital customers by 2024 yearend.Only about half of the patients in the pediatric ICU with AKI who require renal replacement","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DBgJPLFaKqLFthtuMs0zbQ--~B/aD0yODEzO3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/47e842dec478082686e5c6ad96131026","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DBgJPLFaKqLFthtuMs0zbQ--~B/aD0yODEzO3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/47e842dec478082686e5c6ad96131026"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/seastar-medical-reports-third-quarter-220500643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICU","ICUCW","LU1894683264.USD","LU1894683348.USD","HUD","BK4208","CMS","BK4082","LU2637428348.USD","BK4588","BK4585","SCD","LU2346227817.USD"],"gpt_icon":0},{"id":"2483071610","title":"Analysts Offer Insights on Healthcare Companies: TScan Therapeutics (TCRX), Legend Biotech (LEGN) and ICU Medical (ICUI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483071610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483071610?lang=en_us&edition=fundamental","pubTime":"2024-11-13 18:11","pubTimestamp":1731492708,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TScan Therapeutics (TCRX – Research Report), Legend ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tscan-therapeutics-tcrx-legend-biotech-legn-and-icu-medical-icui?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tscan-therapeutics-tcrx-legend-biotech-legn-and-icu-medical-icui?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SG9999015952.SGD","BK4588","LU0106261612.USD","BK4198","ICU","ICUI","BK4585","LU0012050646.USD","SG9999015978.USD","BK4137","LEGN","LU0240878834.USD","LU0205194284.USD","HCSG","BK4505","TCRX","SG9999015986.USD","LU0240877869.USD","BK4539","LU0205193047.USD","BK4082","SG9999015945.SGD"],"gpt_icon":0},{"id":"2483102311","title":"ICU Medical Inc (ICUI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483102311","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483102311?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:16","pubTimestamp":1731482182,"startTime":"0","endTime":"0","summary":"Total Revenue: $580 million, representing a 7% growth on a constant currency basis and 6% on a reported basis.Adjusted EBITDA: $95 million, a 6% increase from the previous year.EPS : $1.59, compared to $1.57 last year.Gross Margin: 37%, slightly better than expected due to favorable product mix and supply chain efficiencies.Free Cash Flow: $16 million, including a $26 million outflow related to accounts receivable purchase program.Consumables Growth: 9% growth on both constant currency and reported basis.IT Systems Business Unit Growth: 10% constant currency growth and 7% on a reported basis.Vital Care Segment: Flat year-over-year on a constant currency and reported basis.Adjusted Operating Expenses: $140 million, representing 24.2% of revenue.GuruFocus has detected 8 Warning Signs with ICUI.ICU Medical Inc  raised its full-year adjusted EPS guidance, reflecting improved outlook and performance in the third quarter.ICU Medical Inc  faces challenges in driving meaningful innovation in t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/isK5vI8nSHB3Z0E8FL1Xvw--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7cbbfbcc3a76dc8127d70fb38806bde3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/isK5vI8nSHB3Z0E8FL1Xvw--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/7cbbfbcc3a76dc8127d70fb38806bde3"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-inc-icui-q3-071622888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICUI","ICU"],"gpt_icon":0},{"id":"2483986340","title":"ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483986340","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483986340?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:45","pubTimestamp":1731451525,"startTime":"0","endTime":"0","summary":"ICU Medical  came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 27.20%. A quarter ago, it was expected that this medical device maker would post earnings of $0.98 per share when it actually produced earnings of $1.56, delivering a surprise of 59.18%.ICU Medical , which belongs to the Zacks Medical - Products industry, posted revenues of $580.07 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.92%. This compares to year-ago revenues of $553.31 million. The company has topped consensus revenue estimates four times over the last four quarters.ICU Medical shares have added about 78.7% since the beginning of the year versus the S&P 500's gain of 25.8%.Investors should be mindful of the fact that the outlook for the industry can h","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fs_R4sd8jCoOMib958Znmg--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fs_R4sd8jCoOMib958Znmg--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-icui-tops-q3-224525687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRBR","ICU","ICUI"],"gpt_icon":0},{"id":"2483065723","title":"ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised","url":"https://stock-news.laohu8.com/highlight/detail?id=2483065723","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483065723?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:15","pubTimestamp":1731449738,"startTime":"0","endTime":"0","summary":"ICU Medical  reported Q3 adjusted earnings late Tuesday of $1.59 per diluted share, up from $1.57 a year earlier.Analysts polled by Capital IQ expected $1.25.Revenue for the quarter ended Sept. 30 was $589.1 million, up from $553.3 million a year earlier. Analysts surveyed by Capital IQ expected $576.7 million.The company raised 2024 adjusted diluted EPS guidance to $5.40 to $5.70 from $4.95 to $5.35. Analysts surveyed by Capital IQ expect $5.22.Shares of ICU Medical were up 6.2% in after-hours activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ICUI","ICU"],"gpt_icon":0},{"id":"2483547066","title":"ICU Medical reports Q3 adjusted EPS $1.59, consensus $1.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2483547066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483547066?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:15","pubTimestamp":1731449719,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $589.13M, consensus $574.7M. Vivek Jain, ICU Medical’s (ICUI) Chief Executive Officer, said, “Third quarter results were general...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/icu-medical-reports-q3-adjusted-eps-1-59-consensus-1-25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/icu-medical-reports-q3-adjusted-eps-1-59-consensus-1-25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICUI","ICU"],"gpt_icon":0},{"id":"2483068170","title":"ICU Medical: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2483068170","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483068170?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:38","pubTimestamp":1731447539,"startTime":"0","endTime":"0","summary":"SAN CLEMENTE, Calif.  — SAN CLEMENTE, Calif.  — ICU Medical Inc.  on Tuesday reported a loss of $33 million in its third quarter.The San Clemente, California-based company said it had a loss of $1.35 per share. Earnings, adjusted for amortization costs and pretax expenses, came to $1.59 per share.The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.25 per share.The medical device maker posted revenue of $589.1 million in the period. Its adjusted revenue was $580.1 million, which also beat Street forecasts. Three analysts surveyed by Zacks expected $574.8 million.ICU Medical expects full-year earnings in the range of $5.40 to $5.70 per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-q3-earnings-snapshot-213859109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICU","ICUI"],"gpt_icon":0},{"id":"2483663052","title":"ICU Medical Q3 2024 Adj EPS $1.59 Beats $1.25 Estimate, Sales $589.13M Beat $574.70M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483663052","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483663052?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:07","pubTimestamp":1731445626,"startTime":"0","endTime":"0","summary":"ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $1.25 by 27.2 percent. This is a 1.27 percent increase over earnings of $1.57 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41919024/icu-medical-q3-2024-adj-eps-1-59-beats-1-25-estimate-sales-589-13m-beat-574-70m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICUI","ICU"],"gpt_icon":0},{"id":"2483052109","title":"ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2483052109","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483052109?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"SAN CLEMENTE, Calif., Nov.  12, 2024  (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2979698/8573/en/ICU-Medical-Announces-Third-Quarter-2024-Results-and-Updates-Its-Fiscal-Year-2024-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240877869.USD","LU0205194284.USD","LU0240878834.USD","SG9999015945.SGD","LU0106261612.USD","SG9999015986.USD","SG9999015952.SGD","SG9999015978.USD","BK4082","BK4198","ICU","LU0012050646.USD","LU0205193047.USD","ICUI"],"gpt_icon":0},{"id":"2483050832","title":"ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050832","media":"PR Newswire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483050832?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market.Joint venture becomes part of a global manufacturing network with scale and redundancy. Intends to add long-term supply resiliency and accelerate IV solutions new product development in North America. Combines Otsuka Pharmaceutical Factory, Inc.'s expertise and global manufacturing scale with ICU Medical's strong North American production and distribution. ICU Medical to provide commercial services to the joint venture. \"Otsuka's scale, experience with U.S. partnerships, and demonstrated long-term investment horizon made them the ideal partner,\" said Vivek Jain, ICU Medical's Chief Executive Officer. \"Their financial strength and dedication to portfolio expansion will provide the stability and choice the North American marke","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/G2uOR_K3rJFTw8bnYKhAow--~B/aD0xMDU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/df4a651db143a59c5d30927a1720a531","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/G2uOR_K3rJFTw8bnYKhAow--~B/aD0xMDU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/df4a651db143a59c5d30927a1720a531"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icu-medical-inc-otsuka-pharmaceutical-210500109.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-inc-otsuka-pharmaceutical-210500109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999015952.SGD","LU0205193047.USD","JYNT","BK4198","BK4185","SG9999015978.USD","LU0106261612.USD","ICUI","SG9999015945.SGD","LU0205194284.USD","SG9999015986.USD","LU0012050646.USD","LU0240878834.USD","BK4082","LU0240877869.USD","ICU"],"gpt_icon":0},{"id":"2482378320","title":"CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2482378320","media":"GlobeNewswire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482378320?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:30","pubTimestamp":1731328200,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J. and HYDERABAD, India, Nov.  11, 2024  (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978226/25359/en/CytoSorbents-And-Converge-Biotech-Announce-Strategic-Partnership-to-Expand-Sepsis-and-Critical-Care-Treatment-with-CytoSorb-in-India.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WRD","ICU","CTSO","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.seastarmedical.com","stockEarnings":[{"period":"1week","weight":-0.216},{"period":"1month","weight":-0.522},{"period":"3month","weight":-0.6989},{"period":"6month","weight":-0.797},{"period":"1year","weight":-0.8613},{"period":"ytd","weight":-0.8229}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.260345},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.111117},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.122984},{"month":4,"riseRate":0.75,"avgChangeRate":-0.043313},{"month":5,"riseRate":0,"avgChangeRate":-0.248056},{"month":6,"riseRate":0.5,"avgChangeRate":-0.044386},{"month":7,"riseRate":0.75,"avgChangeRate":0.039842},{"month":8,"riseRate":0.25,"avgChangeRate":-0.231767},{"month":9,"riseRate":0.75,"avgChangeRate":-0.027957},{"month":10,"riseRate":0.5,"avgChangeRate":0.472322},{"month":11,"riseRate":0.25,"avgChangeRate":-0.336901},{"month":12,"riseRate":0,"avgChangeRate":-0.056877}],"exchange":"NASDAQ","name":"SeaStar Medical Holding Corporation","nameEN":"SeaStar Medical Holding Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SeaStar Medical Holding Corporation(ICU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SeaStar Medical Holding Corporation(ICU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SeaStar Medical Holding Corporation,ICU,SeaStar Medical Holding Corporation股票,SeaStar Medical Holding Corporation股票老虎,SeaStar Medical Holding Corporation股票老虎国际,SeaStar Medical Holding Corporation行情,SeaStar Medical Holding Corporation股票行情,SeaStar Medical Holding Corporation股价,SeaStar Medical Holding Corporation股市,SeaStar Medical Holding Corporation股票价格,SeaStar Medical Holding Corporation股票交易,SeaStar Medical Holding Corporation股票购买,SeaStar Medical Holding Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SeaStar Medical Holding Corporation(ICU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SeaStar Medical Holding Corporation(ICU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}